Skip to main content
P

Petgenoma

Petgenoma provides canine genetic testing services using advanced DNA analysis to identify breed composition, health predispositions, and behavioral traits. Their platform offers detailed insights into over 300 disease markers and genetic factors influencing behavior, empowering pet owners and veterinarians with actionable data for personalized care.

São Paulo, BrazilFounded 202213200+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Pet owners and veterinarians lack accessible, comprehensive genetic insights into canine health and behavior. This gap hinders the implementation of personalized preventative care strategies and a deeper understanding of individual animal needs.

Solution

Petgenoma offers canine genetic testing services utilizing advanced DNA analysis to provide detailed breed composition, health predispositions, and behavioral trait information. The platform employs microarray technology, similar to that used by leading international laboratories, for high-accuracy genetic profiling. By analyzing over 300 disease markers and specific behavioral genes, Petgenoma empowers pet owners and veterinary professionals with actionable data. This data facilitates tailored health management plans, early intervention for potential health issues, and a more informed approach to animal well-being.

Target Audience

The primary target audience includes pet owners seeking to understand their dogs' genetic makeup and health risks, as well as veterinary professionals looking for data-driven tools to inform clinical decisions and personalized pet care.

Features

  • Canine DNA analysis using microarray technology (Illumina platform) for breed composition, health predispositions, and behavioral traits.
  • Identification of predispositions to over 300 diseases based on genetic markers.
  • Assessment of genetic factors influencing behavioral characteristics.
  • Pharmacogenetic analysis to predict individual responses to various medications.
  • Kinship analysis to identify potential genetic risks associated with inbreeding.
  • Home-based DNA sample collection via buccal swabs, with kits shipped directly to customers.
  • Scientific analysis conducted in a Brazilian laboratory with expertise in canine genetics.
  • Results delivered through a comprehensive report detailing genetic insights and actionable recommendations.
  • High accuracy rate of 98% for generated genetic data.
This profile is AI-generated and may contain inaccuracies.